Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Booster shots improve CD8+ T cell response to SARS-CoV-2 in animal model

In a new study, published on the bioRxiv* preprint server, scientists showed in a mice model that three doses of the same synthetic peptide vaccine, eliciting an exclusive CD8+ T cell response against one SARS-CoV-2 Spike epitope, protected against lethal SARS-CoV-2 infection, in the absence of neutralizing antibodies. Researchers also showed that the third dose resulted in superior generation of effector-memory T cells in the circulation and tissue-resident memory T (TRM) cells.

20 Dec 2021

New €8 million multiyear contribution agreement signed to support equitable access for health products

On 16 December 2021 the Government of Belgium and WHO signed a new €8 million multiyear contribution agreement for the period 2021-2025, to support increasing global equitable access to health products and health technologies globally.

20 Dec 2021

An Omicron wave predicted for England from December 2021 to April 2022

A study, published on the medRxiv* preprint server, focuses on the interaction between Omicron variants and public health interventions in England that promote immunity.

20 Dec 2021

New report warns about failure to appreciate the complex nature of environmental risks

Complex risks to human health and wellbeing have been neglected by governments and NGOs because of a failure appreciate the complex nature of environmental risks, a new report warns.

20 Dec 2021

Researchers find a digital silver lining in failed COVID-19 drug trial

A clinical trial in which two test drugs failed to help patients with mild COVID-19 nevertheless had a silver lining: It proved the viability of a study model in which a medication's potential arrhythmic side effects are safely, effectively monitored without the participants ever setting foot in a hospital or clinic.

20 Dec 2021

New oral pill for COVID-19 home treatment

As cases and hospitalizations continue to rise in many countries, new treatments are being sought to arrest the progression of the disease, preventing severe illness and death or disability. One such is the small molecule molnupiravir, the focus of a new research paper.

20 Dec 2021

QTQTN motif upstream of furin-cleavage site in SARS-CoV-2 infection and pathogenesis

A new study posted to the bioRxiv* preprint server aimed to demonstrate whether the loss of the QTQTN motif attenuates SARS-CoV-2 replication in respiratory cells in vitro and pathogenesis in hamsters.

20 Dec 2021

New Omicron variant may be better at evading vaccine-induced antibodies, research shows

The Omicron variant of SARS-CoV-2 may be significantly better than previous variants at evading vaccine-induced antibodies, according to new research from Cambridge - but preliminary evidence suggests it is less likely to cause severe COVID-19 illness in the lungs.

20 Dec 2021

£316 million funding boost to protect tens of thousands of people from homelessness

Tens of thousands of people will be protected from homelessness as a result of a £316 million funding boost, announced by the Department for Levelling Up, Housing and Communities today (21 December 2021).

20 Dec 2021

2020 List of 100+ Outstanding Women Nurses and Midwives unveiled

To mark the end of the Year of the Nurse and Midwife, we are honored to unveil the 2020 List of 100+ Outstanding Women Nurses and Midwives.

20 Dec 2021

SARS-CoV-2 infection leads to distinct changes in proteomic and peptidomic profiles and posttranslational modifications

A new study indicates that as a result of SARS-CoV-2 infection comprehensive changes in protein processing and regulation occur.

20 Dec 2021

£28 million government funding boost to protect and vaccinate rough sleepers

Rough sleepers are being helped to get their COVID-19 vaccines and move into safe accommodation over the winter thanks to a £28 million government funding boost, the Department for Levelling Up, Housing and Communities announced today (20 December 2021).

20 Dec 2021

Pandemic News and Research

Further Reading

Booster shots improve CD8+ T cell response to SARS-CoV-2 in animal model

New €8 million multiyear contribution agreement signed to support equitable access for health products

An Omicron wave predicted for England from December 2021 to April 2022

New report warns about failure to appreciate the complex nature of environmental risks

Researchers find a digital silver lining in failed COVID-19 drug trial

New oral pill for COVID-19 home treatment

QTQTN motif upstream of furin-cleavage site in SARS-CoV-2 infection and pathogenesis

New Omicron variant may be better at evading vaccine-induced antibodies, research shows

£316 million funding boost to protect tens of thousands of people from homelessness

2020 List of 100+ Outstanding Women Nurses and Midwives unveiled

SARS-CoV-2 infection leads to distinct changes in proteomic and peptidomic profiles and posttranslational modifications

£28 million government funding boost to protect and vaccinate rough sleepers

COVID-19 infection during pregnancy found to impact infant neurodevelopment

Cloth facemasks worn during exercise are unlikely to cause significant respiratory changes

A test to identify antibody effectiveness against COVID-19 variants

Anti-SARS-CoV-2 antibody infusion shown to demonstrate robust immune response following COVID-19 vaccination

Vaccine promoters struggle to get people boosted in California’s fields

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

Local pharmacists fill Rx void as big brands pull out of rural areas

Impact of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military personnel

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News